Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | SVP HR Public Affairs & Philan | March 06, 2012 | March 09, 2012 |
| Teligent, Inc.TLGT · Entity 134764 | Director | July 21, 2021 | July 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date March 06, 2012 · Filed March 09, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 142,142 |
Ending reported balance
After 2012-03-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2012-03-06 · Exercise / conversion · Acquired 28,073 · Balance 149,037 F1: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Row 2 · 2012-03-06 · Exercise / conversion · Acquired 4,257 · Balance 153,294 F2: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. Row 3 · 2012-03-06 · Tax withholding · Disposed 1,683 · Balance 151,611 F3: Shares withheld for payment of taxes upon vesting of restricted stock units. Row 4 · 2012-03-06 · Tax withholding · Disposed 9,469 · Balance 142,142 F4: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2016-03-06 | Direct | 10,593 |
Reported balance
After 2012-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2012-03-06 · Grant · Acquired 10,593 · Balance 10,593 F5: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 36,854.93 |
Reported balance
After 2012-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2012-03-06 · Grant · Acquired 10,010 · Balance 36,854.93 F7: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 46,643.93 |
Reported balance
After 2012-03-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2012-03-06 · Grant · Acquired 9,789 · Balance 46,643.93 F10: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F11: Represents performance shares earned under the 2010-2012 Long Term Performance Award. F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 47,477.5823 |
Reported balance
After 2012-03-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2012-03-06 · Other · Acquired 833.6523 · Balance 47,477.5823 F12: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F13: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award. F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 19,404.5823 |
Reported balance
After 2012-03-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2012-03-06 · Exercise / conversion · Disposed 28,073 · Balance 19,404.5823 F7: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F14: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2014-03-31 | Direct | 8,975 |
Reported balance
After 2012-03-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-03-06 · Grant · Acquired 8,975 · Balance 8,975 F15: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F16: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2014-03-31 | Direct | 9,378 |
Reported balance
After 2012-03-06 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-03-06 · Other · Acquired 403 · Balance 9,378 F17: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F18: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2012-03-06 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-03-06 · Exercise / conversion · Disposed 4,257 · Balance 0 F19: Each restricted stock unit converts into one share of common stock upon vesting. F2: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award.
F2: Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested.
F3: Shares withheld for payment of taxes upon vesting of restricted stock units.
F4: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award.
F5: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
F6: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.
F7: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.
F8: Represents performance shares earned under the 2009-2011 Long-Term Performance Award.
F9: This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards.
F10: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.
F11: Represents performance shares earned under the 2010-2012 Long Term Performance Award.
F12: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.
F13: Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award.
F14: This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only.
F15: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.
F16: Represents performance shares earned under the 2011-2013 Long-Term Performance Award.
F17: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.
F18: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award.
F19: Each restricted stock unit converts into one share of common stock upon vesting.
Teligent, Inc.
Report date July 21, 2021 · Filed July 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 150,000 |
Reported balance
After 2021-07-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-07-21 · Grant · Acquired 150,000 · Balance 150,000 F1: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock F3: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50. F2: The shares underlying the derivative securities shall vest fully on the first anniversary of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock
F2: The shares underlying the derivative securities shall vest fully on the first anniversary of grant.
F3: Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 10,100 | $22.73 | $229,573.00 |
DisclosureSEC source: 0000014272-06-000093 · cel527.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,302 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 03, 2006 Filed Mar 6, 2006 21:39 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 788 | $22.79 | $17,958.52 |
DisclosureSEC source: 0000014272-06-000066 · cel517.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,202 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| February 01, 2006 Filed Feb 2, 2006 21:34 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 704 | $22.95 | $16,156.80 |
DisclosureSEC source: 0000014272-06-000023 · cel492.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,990 F1 · kind: Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| December 06, 2005 Filed Dec 8, 2005 21:16 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-05-000208 · cel475.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,694 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| December 06, 2005 Filed Dec 9, 2005 19:53 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantCommon Stock, $0.10 par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-05-000215 · cel479.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,694 F1 · security: This Form 4 is being amended solely to include a footnote to reflect that the number of shares noted in the BMY Savings and Investment Progam is based on a plan statement as of the end of the most recent fiscal quarter. F2 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.